Reactive hypoglycaemia is a condition in which blood glucose drops within two to four hours of eating, causing symptoms such as shakiness, sweating, and dizziness. A common question is: does reactive hypoglycaemia show up on HbA1c? The short answer is no — HbA1c measures average blood glucose over two to three months and cannot detect brief post-meal dips. This article explains why HbA1c is not the right test, which investigations are used in UK clinical practice, when to see your GP, and how reactive hypoglycaemia is managed in line with NHS and NICE guidance.

What Is Reactive Hypoglycaemia and How Is It Diagnosed?

Reactive hypoglycaemia is diagnosed by demonstrating Whipple's triad: a venous plasma glucose below 3.0 mmol/L during symptoms, symptoms consistent with hypoglycaemia, and relief once glucose is restored.

Reactive hypoglycaemia refers to a drop in blood glucose that occurs within two to four hours after eating, typically following a carbohydrate-rich meal. Unlike fasting hypoglycaemia, which occurs after a prolonged period without food, reactive hypoglycaemia is triggered by a post-meal rise in insulin that causes blood glucose to fall to a clinically low level. The underlying mechanism varies: in some people it reflects hyperinsulinaemia; in others it may be related to post-bariatric surgery physiology, early insulin resistance, endocrine disorders, or medication effects. In a proportion of cases no clear cause is found (idiopathic reactive hypoglycaemia).

It is also important to distinguish true reactive hypoglycaemia — where blood glucose falls to a biochemically low level — from idiopathic postprandial syndrome, in which people experience similar symptoms after eating but blood glucose remains within the normal range. The two conditions are managed differently, which is why objective measurement during symptoms is essential.

In the UK, clinically significant hypoglycaemia in non-diabetic adults is defined as a venous plasma glucose below 3.0 mmol/L. Capillary (finger-prick) readings in the range of 3.5–4.0 mmol/L may prompt treatment but are not in themselves diagnostic.

Diagnosis relies on demonstrating Whipple's triad:

• A documented low venous plasma glucose (below 3.0 mmol/L) at the time of symptoms — ideally confirmed by a laboratory sample rather than a capillary reading alone

• Symptoms consistent with hypoglycaemia

• Relief of symptoms once blood glucose is restored to normal

Common symptoms include:

• Shakiness or trembling

• Sweating and palpitations

• Dizziness or light-headedness

• Difficulty concentrating or brain fog

• Hunger shortly after eating

• Anxiety or irritability

A thorough clinical history — including dietary patterns, symptom timing, and any relevant medications — forms the cornerstone of initial assessment. Certain features should prompt urgent specialist referral rather than a dietary approach: episodes occurring during fasting or overnight, neuroglycopenic symptoms (confusion, seizure, or loss of consciousness), unexplained weight change, or clinical features suggesting adrenal insufficiency or an insulin-secreting tumour (insulinoma).

What HbA1c Measures and Its Limitations

HbA1c reflects average blood glucose over two to three months and cannot detect reactive hypoglycaemia; people with the condition will typically have a completely normal HbA1c result.

HbA1c (glycated haemoglobin) is a blood test that reflects average blood glucose levels over the preceding two to three months. It works by measuring the proportion of haemoglobin — the oxygen-carrying protein in red blood cells — that has become glycated (bound to glucose). Because red blood cells have a lifespan of approximately 120 days, HbA1c provides a reliable long-term picture of glycaemic control. In line with NICE guidance (NG28), it is widely used in the UK to diagnose type 2 diabetes and to monitor glycaemic management in people with existing diabetes.

However, HbA1c has important limitations when it comes to detecting reactive hypoglycaemia. Reactive hypoglycaemia does not reliably show up on HbA1c. Because the test reflects an average over weeks and months, brief post-meal dips in blood glucose — even if they are clinically significant — are unlikely to lower the overall average enough to be detectable. Individuals with reactive hypoglycaemia will typically have a completely normal HbA1c, because their fasting and overnight glucose levels remain within range. An HbA1c result might appear slightly elevated only if there is also frequent post-prandial hyperglycaemia or a factor affecting red cell turnover — it should not be assumed to be elevated simply because reactive hypoglycaemia is present.

Additionally, HbA1c can be affected by factors unrelated to glucose metabolism, which may cause it to be falsely raised or lowered:

• Falsely raised: iron-deficiency anaemia, vitamin B12 or folate deficiency

• Falsely lowered: haemolytic anaemia, acute blood loss, or recent blood transfusion

• Method-dependent: haemoglobin variants such as sickle cell trait or haemoglobin C

• Unreliable in: pregnancy, chronic kidney disease, and certain liver conditions

For these reasons, a normal HbA1c result should never be used to rule out reactive hypoglycaemia. A different diagnostic approach is required, as described in the next section.

Which Tests Are Used to Detect Reactive Hypoglycaemia in the UK?

UK clinicians use laboratory sampling during symptomatic episodes, self-monitoring of blood glucose, continuous glucose monitoring, and a supervised mixed-meal tolerance test to diagnose reactive hypoglycaemia.

Given that HbA1c is not an appropriate tool for identifying reactive hypoglycaemia, clinicians in the UK typically use a combination of other investigations to confirm the diagnosis and identify any underlying cause.

Laboratory sampling during symptomatic episodes is the most diagnostically valuable step. Whenever possible, if symptoms occur, a venous blood sample should be taken promptly and sent for:

• Plasma glucose (to confirm biochemical hypoglycaemia, i.e., below 3.0 mmol/L)

• Insulin and C-peptide (to assess endogenous insulin secretion)

• Beta-hydroxybutyrate (suppressed in hyperinsulinaemic hypoglycaemia)

• Sulfonylurea and meglitinide screen (to exclude medication-induced hypoglycaemia)

This panel, taken at the time of symptoms, is central to satisfying Whipple's triad with objective evidence.

Self-monitoring of blood glucose (SMBG) using a finger-prick glucometer is a practical first step for identifying the pattern of episodes. Patients may be asked to check their glucose two to four hours after meals when symptoms occur. Capillary readings are useful for identifying timing and patterns but are less reliable than venous plasma glucose for definitive diagnosis.

Continuous glucose monitoring (CGM) can be a helpful adjunct, capturing post-meal glucose fluctuations in real time without repeated finger-prick testing. However, CGM is not a stand-alone diagnostic tool — it provides pattern information and can guide the timing of confirmatory laboratory sampling, but abnormal findings require verification with a venous plasma glucose measurement.

A supervised mixed-meal tolerance test is the preferred provocative investigation in secondary care for suspected reactive hypoglycaemia. This involves consuming a standardised mixed meal (containing carbohydrate, protein, and fat) and having blood samples taken at regular intervals to observe glucose, insulin, and C-peptide responses. A significant post-meal glucose nadir accompanied by symptoms supports the diagnosis. Note that a prolonged oral glucose tolerance test (OGTT) is generally not recommended for diagnosing reactive hypoglycaemia in UK practice, as it has poor specificity and a high false-positive rate; a mixed-meal test more closely reflects physiological conditions.

Additional investigations may include:

• Liver function tests and morning cortisol to exclude secondary causes such as adrenal insufficiency

• IGF-2 levels in the rare context of suspected non-islet cell tumour hypoglycaemia

A 72-hour supervised fast is used to investigate fasting hypoglycaemia and suspected insulinoma — it is not a test for reactive hypoglycaemia.

Referral to an endocrinologist is appropriate if initial investigations are inconclusive, if an underlying condition such as insulinoma is suspected, or if episodes are severe or recurrent.

When to Speak to a GP About Hypoglycaemia Symptoms

See your GP if you have recurrent post-meal shakiness, dizziness, or sweating; seek urgent care if episodes involve confusion, seizure, loss of consciousness, or occur during fasting.

Not sure if this is normal? Chat with one of our pharmacists →

Many people experience occasional post-meal energy dips or mild shakiness that can be attributed to dietary habits rather than a clinical condition. However, there are specific circumstances in which it is important to seek medical advice.

Contact your GP if you experience:

• Recurrent episodes of dizziness, shakiness, or sweating that consistently occur one to four hours after eating

• Symptoms that are severe enough to interfere with daily activities, work, or concentration

• Symptoms that do not resolve promptly after eating carbohydrates

• Unexplained weight loss alongside hypoglycaemic episodes

Seek urgent medical attention if you experience:

• Loss of consciousness, confusion, or a seizure associated with low blood sugar — these may indicate severe hypoglycaemia requiring immediate treatment

• Episodes occurring during fasting, overnight, or on waking, which may suggest a different underlying cause requiring prompt investigation

1. If you experience symptoms, the immediate self-management steps are:
2. Take 10–15 g of fast-acting carbohydrate (e.g., 150–200 ml of fruit juice, glucose tablets, or a small glass of a sugary drink)
3. Wait 10–15 minutes; if symptoms persist, repeat the fast-acting carbohydrate
4. Once symptoms resolve, follow with a small low-GI snack (e.g., a piece of fruit with a handful of nuts, or oatcakes with peanut butter) to help stabilise blood glucose
5. If symptoms do not resolve or recur rapidly, seek medical help

People taking glucose-lowering medicines — such as insulin, sulphonylureas (e.g., gliclazide), or meglitinides — should contact their diabetes team promptly if hypoglycaemic episodes occur, as medication review and dose adjustment may be needed. Suspected adverse drug reactions, including medication-induced hypoglycaemia, can also be reported to the MHRA via the Yellow Card scheme (yellowcard.mhra.gov.uk).

Driving safety: Do not drive during or immediately after a hypoglycaemic episode. If you experience episodes that cause impairment or loss of consciousness, you should follow DVLA guidance on fitness to drive, which may require you to notify the DVLA and refrain from driving until the condition is assessed and managed.

Keeping a symptom diary — recording the timing of episodes in relation to meals, the foods consumed, and any associated factors — is extremely helpful for your GP and supports a more accurate and timely assessment.

Managing Reactive Hypoglycaemia: NHS Guidance and Next Steps

Dietary modification using a low-GI approach is the primary treatment, with referral to a registered dietitian recommended; medication is rarely required for idiopathic reactive hypoglycaemia.

For most people with reactive hypoglycaemia, dietary modification is the primary and most effective management strategy. NHS dietetic practice and guidance from the British Dietetic Association (BDA) in the UK generally recommend a low glycaemic index (GI) approach, which helps to prevent the sharp post-meal glucose spikes that trigger an exaggerated insulin response.

Key dietary principles include:

• Eating smaller, more frequent meals rather than large portions

• Choosing low-GI carbohydrates such as oats, lentils, wholegrain bread, and most vegetables

• Combining carbohydrates with protein and healthy fats to slow glucose absorption

• Avoiding high-sugar foods and drinks, particularly on an empty stomach

• Limiting alcohol, especially without food, as it can impair glucose regulation

Acute management of symptomatic episodes should follow the steps described in the previous section: fast-acting carbohydrate first, followed by a low-GI snack once symptoms resolve.

Referral to a registered dietitian via your GP or NHS community services is strongly recommended, as individual dietary needs and lifestyle factors vary considerably. BDA resources on glycaemic index and reactive hypoglycaemia provide evidence-based guidance that a dietitian can help you apply in practice.

Where reactive hypoglycaemia is associated with early insulin resistance or pre-diabetes, lifestyle interventions — including regular physical activity and, where appropriate, weight management — may also help to improve insulin sensitivity over time.

Medication is rarely required for idiopathic reactive hypoglycaemia. In specific clinical scenarios, such as post-bariatric surgery hypoglycaemia, specialist pharmacological management may be considered; however, such treatments are specialist-led, often used off-label, and highly individualised. Management in this context should be guided by a specialist team with expertise in bariatric medicine, in line with guidance from organisations such as the British Obesity and Metabolic Surgery Society (BOMSS) and the Society for Endocrinology.

Where an underlying cause is identified — such as an insulinoma or adrenal insufficiency — treatment will be directed at the primary condition.

In summary, reactive hypoglycaemia does not show up on HbA1c, but it is a diagnosable and manageable condition. If you suspect you are experiencing post-meal hypoglycaemia, speaking to your GP and requesting appropriate investigations is the right first step towards effective management and improved quality of life.

Frequently Asked Questions